MARKET

RGEN

RGEN

Repligen
NASDAQ
151.17
-3.79
-2.45%
After Hours: 150.01 -1.16 -0.77% 16:03 10/03 EDT
OPEN
153.80
PREV CLOSE
154.96
HIGH
155.26
LOW
150.10
VOLUME
490.55K
TURNOVER
0
52 WEEK HIGH
225.62
52 WEEK LOW
134.64
MARKET CAP
8.43B
P/E (TTM)
62.52
1D
5D
1M
3M
1Y
5Y
Repligen: Current Market Values Well Supported, Valuations Are Not, Reiterate Hold
Seeking Alpha · 15h ago
Morgan Stanley: 81 companies will have technical pressures due to tax loss selling
Seeking Alpha · 18h ago
Analysts Have Conflicting Sentiments on These Healthcare Companies: Haemonetics (HAE), Repligen (RGEN) and Ginkgo Bioworks Holdings (DNA)
TipRanks · 2d ago
Weekly Report: what happened at RGEN last week (0925-0929)?
Weekly Report · 2d ago
Is There An Opportunity With Repligen Corporation's (NASDAQ:RGEN) 22% Undervaluation?
Simply Wall St · 5d ago
Repligen: Statement of changes in beneficial ownership of securities
Press release · 6d ago
Repligen: Initial statement of beneficial ownership of securities
Press release · 6d ago
Repligen (RGEN) to Acquire Fluid Management Company Metenova
NASDAQ · 09/27 10:51
More
About RGEN
Repligen Corporation is a life sciences company, which develops and commercializes bioprocessing technologies and systems that rises flexibility in the process of manufacturing biological drugs. The Company's bioprocessing business consist of four franchises, filtration; chromatography; process analytics; and proteins. The Filtration products are used in process development and process scale production. The Chromatography franchise includes products used in downstream purification, development, and manufacturing of biological drugs. The Process Analytics products allow end-users to make in-line absorbance measurements allowing for the determination of protein concentration in filtration, chromatography formulation and fill-finish applications. The Proteins franchise is represented by its Protein A affinity ligands, which are a critical component of Protein A chromatography resins used in downstream purification of virtually all monoclonal antibody (mAb) based drugs on the market.

Webull offers kinds of Repligen Corp stock information, including NASDAQ:RGEN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, RGEN stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading RGEN stock methods without spending real money on the virtual paper trading platform.